Filing Details
- Accession Number:
- 0001104659-24-022538
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-13 20:47:39
- Reporting Period:
- 2024-02-09
- Accepted Time:
- 2024-02-13 20:47:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | Pharmaceutical Preparations (2834) | 462159271 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801372 | Kayden Jennifer Lee | C/O Rhythm Pharmaceuticals, Inc. 222 Berkeley Street, 12Th Floor Boston MA 02116 | Evp, Head Of North America | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-09 | 3,438 | $0.00 | 6,459 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-11 | 2,031 | $0.00 | 8,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-12 | 1,023 | $51.38 | 7,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-13 | 615 | $49.83 | 6,852 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-02-09 | 3,438 | $0.00 | 3,438 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-02-11 | 2,031 | $0.00 | 2,031 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,874 | No | 4 | M | Direct | ||
| 2,031 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
- The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
Billionaire Hedge Funds
